Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Comprehensive Loss

v3.26.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
REVENUES $ 3,671 $ 7,760
COST OF REVENUES 2,453 3,490
GROSS PROFIT 1,218 4,270
OPERATING EXPENSES:    
Research and development expenses 2,638 2,383
Sales and marketing expenses 2,866 2,639
General and administrative expenses 2,899 3,169
Other Income (163)
TOTAL OPERATING EXPENSES 8,403 8,028
OPERATING LOSS (7,185) (3,758)
Interest expenses (251) (618)
Other financial (expense) income, net (825) 2
NET COMPREHENSIVE LOSS FOR THE YEAR $ (8,261) $ (4,374)
Net loss per share attributable to common shareholders – basic (in Dollars per share) [1] $ (5.68) $ (8.5)
Net loss per share attributable to common shareholders diluted (in Dollars per share) [1] $ (5.68) $ (8.5)
Weighted average number of common stocks used in computing net loss per share – basic (in Shares) 1,454,785 514,605
Weighted average number of common stocks used in computing net loss per share diluted (in Shares) 1,454,785 514,605
[1] Adjusted to reflect reverse stock split, see note 2(bb).